Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia

Hypertension

Volumn 61, Issue 2, 2013, Pages 472-479

  Siddiqui, Athar H ^a,b   Irani, Roxanna A ^a   Zhang, Weiru ^a   Wang, Wei ^a   Blackwell, Sean C ^a   Kellems, Rodney E ^a   Xia, Yang ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

agonistic autoantibodies; aldosterone; angiotensin receptor; preeclampsia; soluble Fms like tyrosine kinase 1

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; AUTOANTIBODY; EPITOPE; IMMUNOGLOBULIN G; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADRENAL GLAND; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MOUSE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA;

ADOPTIVE TRANSFER; ADRENAL GLANDS; ADULT; ALDOSTERONE; ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MICE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84873055874     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00157     Document Type: Article

References (35)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on research on hypertension during pregnancy. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension. 2003;41:437-445. (Pubitemid 36314613)
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799. (Pubitemid 40311367)
3. Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med. 2006;355:1056-1058. (Pubitemid 44343551)
4. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173-192.
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658. (Pubitemid 36278583)
6. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fmslike tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005;57(5 pt 2):1R-7R. (Pubitemid 40593239)
7. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, Day MC, Ramin SM, Ahmed A, Kellems RE, Xia Y. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension. 2008;51:1010-1019. (Pubitemid 351398948)
8. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig. 2003;10:82-93. (Pubitemid 36184763)
9. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952. (Pubitemid 29169601)
10. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-2387. (Pubitemid 30329128)
11. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14:855-862.
12. Wenzel K, Rajakumar A, Haase H, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77-84.
13. Siddiqui AH, Irani RA, Zhang Y, Dai Y, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice. Am J Hypertens. 2011;24:606-612.
14. Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension. 2010;55:386-393.
15. Skinner SL, Lumbers ER, Symonds EM. Analysis of changes in the reninangiotensin system during pregnancy. Clin Sci. 1972;42:479-488.
16. Irani RA, Xia Y. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol. 2011;31:47-58.
17. Elsheikh A, Creatsas G, Mastorakos G, Milingos S, Loutradis D, Michalas S. The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet. 2001;264:182-185. (Pubitemid 32105008)
18. Bussen SS, Sütterlin MW, Steck T. Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. Acta Obstet Gynecol Scand. 1998;77:609-613. (Pubitemid 28416505)
19. Langer B, Grima M, Coquard C, Bader AM, Schlaeder G, Imbs JL. Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet Gynecol. 1998;91:196-202. (Pubitemid 28074147)
20. de Groot CJ, Taylor RN. New insights into the etiology of pre-eclampsia. Ann Med. 1993;25:243-249. (Pubitemid 23209467)
21. Escher G, Mohaupt M. Role of aldosterone availability in preeclampsia. Mol Aspects Med. 2007;28:245-254. (Pubitemid 46843192)
22. Gennari-Moser C, Khankin EV, Schüller S, Escher G, Frey BM, Portmann CB, Baumann MU, Lehmann AD, Surbek D, Karumanchi SA, Frey FJ, Mohaupt MG. Regulation of placental growth by aldosterone and cortisol. Endocrinology. 2011;152:263-271.
23. Magennis DP, McNicol AM. Vascular patterns in the normal and pathological human adrenal cortex. Virchows Arch. 1998;433:69-73. (Pubitemid 28356479)
24. Bernini GP, Moretti A, Bonadio AG, Menicagli M, Viacava P, Naccarato AG, Iacconi P, Miccoli P, Salvetti A. Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endocrinol Metab. 2002;87: 4961-4965. (Pubitemid 35316333)
25. Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery. 2002;132:1056-63; discussion 1063. (Pubitemid 36026955)
26. Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol. 2002;161:1235-1246.
27. Gilbert JS, Verzwyvelt J, Colson D, Arany M, Karumanchi SA, Granger JP. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia- induced hypertension. Hypertension. 2010;55:380-385.
28. Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev. 1995;16:608-648.
29. Walsh SW. Progesterone and estradiol production by normal and preeclamptic placentas. Obstet Gynecol. 1988;71:222-226. (Pubitemid 18053484)
30. Féraud O, Mallet C, Vilgrain I. Expressional regulation of the angiopoietin- 1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repair. Endocrinology. 2003;144:4607-4615. (Pubitemid 37204860)
31. Mallet C, Feraud O, Ouengue-Mbele G, Gaillard I, Sappay N, Vittet D, Vilgrain I. Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH. Am J Physiol Endocrinol Metab. 2003;284:E156-E167. (Pubitemid 36076234)
32. Taniguchi A, Tajima T, Nonomura K, Shinohara N, Mikami A, Koyanagi T. Expression of vascular endothelial growth factor and its receptors Flk-1 and Flt-1 during the regeneration of autotransplanted adrenal cortex in the adrenalectomized rat. J Urol. 2004;171(6 pt 1):2445-2449. (Pubitemid 38625512)
33. Vittet D, Ciais D, Keramidas M, De Fraipont F, Feige JJ. Paracrine control of the adult adrenal cortex vasculature by vascular endothelial growth factor. Endocr Res. 2000;26:843-852. (Pubitemid 32053110)
34. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65: 2003-2017. (Pubitemid 38669987)
35. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005;67:2101-2113. (Pubitemid 41623372)